{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihkkidio5ktzvknrughrwlqfvmokhydmcoaq3ohc7bni3b3wxkrhq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mouze3xrbkw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic2etm3vum223cpvz64oukjtoth5xkpz7jtgkgyjhutdrzopdt7py"
    },
    "mimeType": "image/jpeg",
    "size": 131973
  },
  "path": "/2026/06/22/abbvie-apogee-acquisition-immunology-zumilokibart/?utm_campaign=rss",
  "publishedAt": "2026-06-22T11:45:55.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "drug development",
    "STAT+"
  ],
  "textContent": "AbbVie is buying Apogee Therapeutics, the developer of an experimental atopic dermatitis drug, for nearly $11B, continuing a run of pharma acquisitions.",
  "title": "STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal",
  "updatedAt": "2026-06-22T11:53:13.000Z"
}